Symbol="LPCN"
AssetType="Common Stock"
Name="Lipocine Inc"
Description="Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceuticals for the treatment of metabolic and endocrine disorders. The company is headquartered in Salt Lake City, Utah."
CIK="1535955"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="26084700"
EBITDA="-13313815"
PERatio="None"
PEGRatio="0"
BookValue="6.14"
DividendPerShare="0"
DividendYield="0"
EPS="-2.19"
RevenuePerShareTTM="0.107"
ProfitMargin="0"
OperatingMarginTTM="-24.01"
ReturnOnAssetsTTM="-0.204"
ReturnOnEquityTTM="-0.3"
RevenueTTM="554990"
GrossProfitTTM="500000"
DilutedEPSTTM="-2.19"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="36.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.356"
PriceToBookRatio="0.953"
EVToRevenue="441.02"
EVToEBITDA="-1.116"
Beta="0.96"
num_52WeekHigh="12.41"
num_52WeekLow="3.3"
num_50DayMovingAverage="4.672"
num_200DayMovingAverage="6.21"
SharesOutstanding="5206500"
DividendDate="None"
ExDividendDate="None"
symbol="LPCN"
open="5.00"
high="5.15"
low="4.84"
price="5.08"
volume="63222.00"
latest_trading_day="2023-08-11"
previous_close="5.01"
change="0.07"
change_percent="1.3972%"
aroon_positive_momentum_days="3"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="3"
Volume_recent_avg="201460"
Change_recent_avg="0.01"
Delta_recent_avg="0.23"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.14"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="3"
Aroon_momentum_negative="97"
image_negative_thumbnail_id_1="1155"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0189.jpeg"
image_negative_thumbnail_id_2="1110"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0143.jpeg"
image_neutral_thumbnail_id_1="524"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_neutral_thumbnail_id_2="538"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_positive_thumbnail_id_1="678"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0030.jpeg"
image_positive_thumbnail_id_2="689"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0019.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
